Author Correction: CRISPR technologies for genome, epigenome and transcriptome editing

Lukas Villiger^#¹, Julia Joung^#^{2

3}, Luke Koblan^{2

3}, Jonathan Weissman^{2

3

4

5}, Omar O Abudayyeh⁶, Jonathan S Gootenberg⁷

Affiliations

¹ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA.
² Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
³ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁶ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA. omar@abudayyeh.science.
⁷ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA. jgoot@mit.edu.

^# Contributed equally.

Published Erratum

Lukas Villiger et al. Nat Rev Mol Cell Biol. 2024 Jun.

. 2024 Jun;25(6):510.

doi: 10.1038/s41580-024-00745-9.

Lukas Villiger^#¹, Julia Joung^#^{2

3}, Luke Koblan^{2

3}, Jonathan Weissman^{2

3

4

5}, Omar O Abudayyeh⁶, Jonathan S Gootenberg⁷

¹ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA.
² Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
³ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁶ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA. omar@abudayyeh.science.
⁷ McGovern Institute for Brain Research, Massachusetts Institute of Technology Cambridge, Cambridge, MA, USA. jgoot@mit.edu.

^# Contributed equally.

No abstract available

Erratum for

CRISPR technologies for genome, epigenome and transcriptome editing.
Villiger L, Joung J, Koblan L, Weissman J, Abudayyeh OO, Gootenberg JS. Villiger L, et al. Nat Rev Mol Cell Biol. 2024 Jun;25(6):464-487. doi: 10.1038/s41580-023-00697-6. Epub 2024 Feb 2. Nat Rev Mol Cell Biol. 2024. PMID: 38308006 Review.